The implementation of new solutions to share electronically the eCRF PDFs with sites have brought up new considerations and challenges to this process.

We would like everyone to share their experiences on how the process has been implemented, as well as the challenges experienced. This will be a group discussion on the recommendations to make this process as straight forward as possible for Sites and Sponsors, while complying with requirements.

Facilitated by Carmen Jiménez, Eli Lilly

Background vector created by YusufSangdes - www.freepik.com

In July 2020, EMA released a new Q&A to provide further expectations on continuous oversight and frequency of investigators’ signature collection on eCRF data reported to the sponsor. Prior to filing a marketing authorization application, all eCRF data should be signed and dated. But also important data such as that related to reporting of SAEs, adjudication of important events and endpoint data, DSMB review, should be signed off in a timely manner. In addition, a timely review and sign-off of data that are entered directly into the CRF as source is particularly important.

The intent of this webinar is to identify if there are new challenges, and if any – to proceed with an update to the eCF best practices on investigator signatures document that was released in 2017.

The eClinical Forum website was disabled for a while because of a ransomware attack at our hosting company. We apologise for any inconvenience that this might have caused.

We have succeeded in restoring the site to a new server and it is now available again for general use. We are still in the process of testing and reconfiguring the site and so some aspects may not work at expected. We ask for your patience while we bring everything back online. 

If you do encounter problems and need to contact us, then we are always available at...

esra@eclinicalforum.org for eSRA related questions

webinars@eclinicalforum.org for webinar registrations and questions

info@eclinicalforum.org for membership and general enquiries

Presenter:  Dr. Jules Mitchel, Target Health

About this Topic:  Clearly, the implementation of traditional clinical research studies as well as executing COVID-19 studies themselves. have been dramatically impacted by global COVID-19 pandemic.  Since showing up at clinical sites in general is becoming less feasible, clinical research must adapt. While there are many exciting ideas to execute virtual and remote studies, the focus still needs to be on the assurances that 1. the clinical sites understand and are following the protocol; 2. the data can and are being entered and reviewed in “real time,” 3. there are the “absence of errors that matter” and 4. the “data are fit for purpose.”  This session will showcase several studies using the Target Health web-based application, with Informed Consent fully integrated with real time direct data capture, real time reports, online monitoring reports and safety reporting.